SINTX Technologies Expands Footprint with Acquisition of SiNAPTIC Surgical Assets to Enter $1.3B Foot and Ankle Fusion Market
SINTX Technologies Inc., an advanced ceramics company focused on medical device innovation, has announced its acquisition of the surgical business assets of SiNAPTIC Holdings, LLC. This strategic move is aimed at expanding SINTX's product portfolio in the $1.3 billion foot and ankle fusion market. The acquisition brings patented implant designs and a seasoned executive team to SINTX, enhancing its capabilities in product development, regulatory strategy, and commercialization. Key members from SiNAPTIC will join SINTX in pivotal roles, including Dr. Bryan Scheer as Chairman of the Clinical Advisory Board. The company plans to leverage its FDA-registered and ISO-certified quality system to streamline regulatory approvals and accelerate the development of disruptive products.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SINTX Technologies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001641172-25-016891), on June 27, 2025, and is solely responsible for the information contained therein.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。